Average Co-Inventor Count = 11.55
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (14 from 1,975 patents)
2. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
15 patents:
1. 12180226 - Spirotricycle RIPK1 inhibitors and methods of uses thereof
2. 9776995 - Bicyclic sulfonamide compounds as sodium channel inhibitors
3. 9663508 - Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
4. 9505749 - Quinazolinone compounds and derivatives thereof
5. 9458152 - Bicyclic sulfonamide compounds as sodium channel inhibitors
6. 9346798 - Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
7. 9340549 - Oxazolidinone compounds and derivatives thereof
8. 9334269 - Carboxamides as inhibitors of voltage-gated sodium channels
9. 9212182 - Bicyclic sulfonamide compounds as sodium channel inhibitors
10. 9012443 - Bicyclic aryl and heteroaryl sodium channel inhibitors
11. 8883782 - Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
12. 7776867 - Furanopyrimidines
13. 7776869 - Heteroaryl-substituted alkyne compounds and method of use
14. 7763624 - Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors
15. 7754717 - Bis-aryl amide compounds and methods of use